Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 3/2013

01-06-2013 | Technical Note

MR-guided Periarterial Ethanol Injection for Renal Sympathetic Denervation: A Feasibility Study in Pigs

Authors: F. Streitparth, A. Walter, N. Stolzenburg, L. Heckmann, J. Breinl, J. L. Rinnenthal, A. Beck, M. De Bucourt, J. Schnorr, U. Bernhardt, B. Gebauer, B. Hamm, R. W. Günther

Published in: CardioVascular and Interventional Radiology | Issue 3/2013

Login to get access

Abstract

Purpose

To evaluate the feasibility and efficacy of image-guided periarterial ethanol injection as an alternative to transluminal radiofrequency ablation.

Methods

Unilateral renal periarterial ethanol injection was performed under general anesthesia in 6 pigs with the contralateral kidney serving as control. All interventions were performed in an open 1.0 T MRI system under real-time multiplanar guidance. The injected volume was 5 ml (95 % ethanol labelled marked MR contrast medium) in 2 pigs and 10 ml in 4 pigs. Four weeks after treatment, the pigs underwent MRI including MRA and were killed. Norepinephrine (NE) concentration in the renal parenchyma served as a surrogate parameter to analyze the efficacy of sympathetic denervation. In addition, the renal artery and sympathetic nerves were examined histologically to identify evidence of vascular and neural injury.

Results

In pigs treated with 10 ml ethanol, treatment resulted in neural degeneration. We found a significant reduction of NE concentration in the kidney parenchyma of 53 % (p < 0.02) compared with the untreated contralateral kidney. In pigs treated with 5 ml ethanol, no significant changes in histology or NE were observed. There was no evidence of renal arterial stenosis in MRI, macroscopy or histology in any pig.

Conclusion

MR-guided periarterial ethanol injection was feasible and efficient for renal sympathetic denervation in a swine model. This technique may be a promising alternative to the catheter-based approach in the treatment of resistant arterial hypertension.
Literature
1.
go back to reference Wolf-Maier K, Cooper RS, Kramer H et al (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43:10–17PubMedCrossRef Wolf-Maier K, Cooper RS, Kramer H et al (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43:10–17PubMedCrossRef
2.
go back to reference Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913PubMedCrossRef Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913PubMedCrossRef
3.
go back to reference Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121:e46–e215PubMedCrossRef Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121:e46–e215PubMedCrossRef
4.
go back to reference Esler M, Jennings G, Korner P et al (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3–20PubMedCrossRef Esler M, Jennings G, Korner P et al (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3–20PubMedCrossRef
5.
go back to reference Schlaich MP, Lambert E, Kaye DM et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43:169–175PubMedCrossRef Schlaich MP, Lambert E, Kaye DM et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43:169–175PubMedCrossRef
6.
go back to reference Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281PubMedCrossRef Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281PubMedCrossRef
7.
go back to reference Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909PubMedCrossRef Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909PubMedCrossRef
8.
go back to reference Simplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917CrossRef Simplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917CrossRef
9.
go back to reference Lee MJ, Mueller PR, vanSonnenberg E et al (1993) CT-guided celiac ganglion block with alcohol. AJR Am J Roentgenol 161:633–636PubMedCrossRef Lee MJ, Mueller PR, vanSonnenberg E et al (1993) CT-guided celiac ganglion block with alcohol. AJR Am J Roentgenol 161:633–636PubMedCrossRef
10.
go back to reference Schmid MR, Kissling RO, Curt A et al (2006) Sympathetic skin response: monitoring of CT-guided lumbar sympathetic blocks. Radiology 241:595–602PubMedCrossRef Schmid MR, Kissling RO, Curt A et al (2006) Sympathetic skin response: monitoring of CT-guided lumbar sympathetic blocks. Radiology 241:595–602PubMedCrossRef
11.
go back to reference Huttner S, Huttner M, Neher M, Antes G (2002) CT-guided sympathicolysis in peripheral artery disease—indications, patient selection and long-term results. Rofo 174:480–484PubMedCrossRef Huttner S, Huttner M, Neher M, Antes G (2002) CT-guided sympathicolysis in peripheral artery disease—indications, patient selection and long-term results. Rofo 174:480–484PubMedCrossRef
12.
go back to reference Streitparth F, Walter T, Wonneberger U et al (2010) Image-guided spinal injection procedures in open high-field MRI with vertical field orientation: feasibility and technical features. Eur Radiol 20:395–403PubMedCrossRef Streitparth F, Walter T, Wonneberger U et al (2010) Image-guided spinal injection procedures in open high-field MRI with vertical field orientation: feasibility and technical features. Eur Radiol 20:395–403PubMedCrossRef
13.
go back to reference Bauch HJ, Kelsch U, Hauss WH (1986) A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection. J Clin Chem Clin Biochem 24:651–658PubMed Bauch HJ, Kelsch U, Hauss WH (1986) A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection. J Clin Chem Clin Biochem 24:651–658PubMed
14.
go back to reference Rippy MK, Zarins D, Barman NC et al (2011) Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 100:1095–1101PubMedCrossRef Rippy MK, Zarins D, Barman NC et al (2011) Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 100:1095–1101PubMedCrossRef
15.
go back to reference Esler M, Schlaich M, Sobotka P et al (2009) Catheter-based renal denervation reduces total body and renal noradrenaline spillover and blood pressure in resistant hypertension. J Hypertens 27(suppl 4):s167 Esler M, Schlaich M, Sobotka P et al (2009) Catheter-based renal denervation reduces total body and renal noradrenaline spillover and blood pressure in resistant hypertension. J Hypertens 27(suppl 4):s167
Metadata
Title
MR-guided Periarterial Ethanol Injection for Renal Sympathetic Denervation: A Feasibility Study in Pigs
Authors
F. Streitparth
A. Walter
N. Stolzenburg
L. Heckmann
J. Breinl
J. L. Rinnenthal
A. Beck
M. De Bucourt
J. Schnorr
U. Bernhardt
B. Gebauer
B. Hamm
R. W. Günther
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 3/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-013-0570-x

Other articles of this Issue 3/2013

CardioVascular and Interventional Radiology 3/2013 Go to the issue

CIRSE Standards of Practice Guidelines

Standards of Practice in Transarterial Radioembolization